Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Other financing activities (2023 - 2025)

Onconetix (ONCO) has disclosed Other financing activities for 2 consecutive years, with $400000.0 as the latest value for Q1 2024.

  • On a quarterly basis, Other financing activities rose 2480.65% to $400000.0 in Q1 2024 year-over-year; TTM through Dec 2024 was $400000.0, a 38.75% increase, with the full-year FY2024 number at $400000.0, up 95.03% from a year prior.
  • Other financing activities was $400000.0 for Q1 2024 at Onconetix, up from $272781.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $400000.0 in Q1 2024 to a low of $15500.0 in Q1 2023.